One of the world's leading vaccine manufacturers is seeking the rapid deployment to those at risk of a product it claims could prevent bird flu developing into a lethal human pandemic.

Rino Rappuoli, chief scientific officer and head of research at Chiron, the US-based group, said a recently completed study supported by his company over the past eight years provided "compelling" data that a vaccine against bird flu was possible.